21 May 2013
Keywords: gsk, submits, lapatinib, nda, japan, japanese, unit
Article | 09 April 2007
The Japanese unit of UK drug major GlaxoSmithKline has submitted a New Drug Application to the domestic regulator for approval ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 April 2007
19 March 2007
23 April 2007
© 2013 thepharmaletter.com